Back to today’s briefing

Story perspectives

Harvard Breakthrough: Gene Editing Corrects Childhood AHC in Mice

7/22/2025

49 8

Summary

Story summary

In a groundbreaking study, Harvard and Jackson Laboratory researchers have successfully used in vivo prime editing to correct genetic mutations responsible for Alternating Hemiplegia of Childhood (AHC) in mice. This promising advancement paves the way for innovative treatments for AHC and other neurological disorders, with future efforts aimed at refining delivery methods for clinical use.

1 of 1

Story summary

In a groundbreaking study, Harvard and Jackson Laboratory researchers have successfully used in vivo prime editing to correct genetic mutations responsible for Alternating Hemiplegia of Childhood (AHC) in mice. This promising advancement paves the way for innovative treatments for AHC and other neurological disorders, with future efforts aimed at refining delivery methods for clinical use.